Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Product (Oral Contraceptives, Intrauterine Devices, Hormonal Injectables, Vaginal Rings, Implants, Transdermal Skin Patches, Others), By Hormone Type (Combined Hormone Contraceptive, Progestin Only) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 05, 2025 | Author: Debashree B | Format:

Market Segmentation

  1. Hormonal Contraceptive Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Oral Contraceptives
    2. Intrauterine Devices
    3. Hormonal Injectables
    4. Vaginal Rings
    5. Implants
    6. Transdermal Skin Patches
    7. Others
  2. Hormonal Contraceptive Market, By Hormone Type 2022-2034 (USD MILLION/ Units)
    1. Combined Hormone Contraceptive
    2. Progestin Only
  3. Regional Hormonal Contraceptive Market
    1. North America
      1. North America Hormonal Contraceptive Market By Product 2022-2034 (USD MILLION/ Units)
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
      2. North America Hormonal Contraceptive Market By Hormone Type 2022-2034 (USD MILLION/ Units)
        1. Combined Hormone Contraceptive
        2. Progestin Only
      3. U.S.
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      4. Canada
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
    2. Europe
      1. Europe Hormonal Contraceptive Market By Product 2022-2034 (USD MILLION/ Units)
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
      2. Europe Hormonal Contraceptive Market By Hormone Type 2022-2034 (USD MILLION/ Units)
        1. Combined Hormone Contraceptive
        2. Progestin Only
      3. U.K.
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      4. Germany
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      5. France
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      6. Spain
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      7. Italy
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      8. Russia
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      9. Nordic
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      10. Benelux
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      11. Rest of Europe
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
    3. APAC
      1. APAC Hormonal Contraceptive Market By Product 2022-2034 (USD MILLION/ Units)
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
      2. APAC Hormonal Contraceptive Market By Hormone Type 2022-2034 (USD MILLION/ Units)
        1. Combined Hormone Contraceptive
        2. Progestin Only
      3. China
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      4. Korea
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      5. Japan
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      6. India
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      7. Australia
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      8. Taiwan
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      9. South East Asia
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      10. Rest of Asia-Pacific
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
    4. Middle East and Africa
      1. Middle East and Africa Hormonal Contraceptive Market By Product 2022-2034 (USD MILLION/ Units)
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
      2. Middle East and Africa Hormonal Contraceptive Market By Hormone Type 2022-2034 (USD MILLION/ Units)
        1. Combined Hormone Contraceptive
        2. Progestin Only
      3. UAE
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      4. Turkey
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      5. Saudi Arabia
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      6. South Africa
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      7. Egypt
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      8. Nigeria
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      9. Rest of MEA
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
    5. LATAM
      1. LATAM Hormonal Contraceptive Market By Product 2022-2034 (USD MILLION/ Units)
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
      2. LATAM Hormonal Contraceptive Market By Hormone Type 2022-2034 (USD MILLION/ Units)
        1. Combined Hormone Contraceptive
        2. Progestin Only
      3. Brazil
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      4. Mexico
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      5. Argentina
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      6. Chile
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      7. Colombia
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only
      8. Rest of LATAM
        1. Oral Contraceptives
        2. Intrauterine Devices
        3. Hormonal Injectables
        4. Vaginal Rings
        5. Implants
        6. Transdermal Skin Patches
        7. Others
        8. Combined Hormone Contraceptive
        9. Progestin Only

We are featured on: